Scarica l'app Stockscreener
1.79
5.92%
0.10
Dopo l'orario di chiusura:
1.80
0.01
+0.56%
Precedente Chiudi:
$1.69
Aprire:
$1.7
Volume 24 ore:
167.66K
Relative Volume:
0.11
Capitalizzazione di mercato:
$140.28M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-6.28%
1M Prestazione:
-36.52%
6M Prestazione:
+39.84%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.695
$1.80
Intervallo di 1 settimana:
$1.67
$1.9877
Portata 52W:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Nome
Citius Oncology Inc
Settore
Telefono
(908) 967-6677
Indirizzo
11 COMMERCE DRIVE, CRANFORD
Confronta CTOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
1.79 | 134.80M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-27 | Iniziato | Maxim Group | Buy |
Citius Oncology Inc Borsa (CTOR) Ultime notizie
Citius Oncology Inc. stock chart pattern explained2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser
Identifying reversal signals in Citius Oncology Inc.Earnings Trend Report & Real-Time Market Sentiment Alerts - Newser
Citius Oncology Beats Fiscal Q3 EPS - AOL.com
Citius Oncology Beats Q3 EPS Estimates with $0 Revenue - AInvest
Citius Oncology (CTOR) $9M Offering; Cash Runway Through Sept 2025 | TENKU SEC FilingForm 10-Q - Stock Titan
Citius Secures $21.5M Funding as Cancer Drug LYMPHIR Nears Q4 2025 Commercial Launch - Stock Titan
Risk adjusted return profile for Citius Oncology Inc. analyzedPrice Forecast Based on AI Analysis - Newser
Citius Oncology Announces Pricing of $9.0 Million Public Offering - ADVFN Brasil
Smart tools for monitoring Citius Oncology Inc.’s price actionHigh Yield Signals with Entry Timing - Newser
Citius Oncology Inc. stock trend outlook and recovery pathStrategy Chart for Real-Time Trade Flow - Newser
Chart overlay techniques for tracking Citius Oncology Inc.Free Capital Protection Trading Strategies - Newser
Is Now a Good Time to Reenter Citius Oncology Inc.Watchlist for Low Risk High Return Stocks Updated - beatles.ru
Citius Oncology IncAnticipates Commercial Launch of Lymphir in 2025 - 富途牛牛
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga
What analysts say about Citius Oncology Inc. stockMaximize gains with proven stock analysis - Jammu Links News
What institutional investors are buying Citius Oncology Inc. stockInvest smarter with expert stock recommendations - Jammu Links News
What is the risk reward ratio of investing in Citius Oncology Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
How volatile is Citius Oncology Inc. stock compared to the marketGet professional advice for portfolio optimization - Jammu Links News
Does Citius Oncology Inc. stock perform well during market downturnsUnlock real-time stock alerts for quick profits - Jammu Links News
How strong is Citius Oncology Inc. company’s balance sheetSkyrocketing returns - Jammu Links News
What are the latest earnings results for Citius Oncology Inc.Free Stock Market Trend Analysis - Jammu Links News
Why is Citius Oncology Inc. stock attracting strong analyst attentionAchieve breakthrough investment performance - Jammu Links News
What is Citius Oncology Inc. company’s growth strategyBuild a portfolio for long-term financial success - Jammu Links News
Should I hold or sell Citius Oncology Inc. stock in 2025Capitalize on market trends early - Jammu Links News
What drives Citius Oncology Inc. stock priceGet timely market insights for better trades - Jammu Links News
What are analysts’ price targets for Citius Oncology Inc. in the next 12 monthsFree Daily Trading Room Entry - Jammu Links News
How does Citius Oncology Inc. compare to its industry peersBreakthrough stock performance - Jammu Links News
How does Citius Oncology Inc. generate profit in a changing economyPost Market Target Finder To Watch Now - Jammu Links News
What makes Citius Oncology Inc. stock attractive to long term investorsPortfolio Diversification Stock Ideas From Experts - metal.it
Published on: 2025-07-29 19:38:23 - metal.it
Trendline Breach Raises Concern for Citius Oncology Inc. InvestorsFundamental + Technical Hybrid Stock Tips Shared - metal.it
Relative strength of Citius Oncology Inc. in sector analysisFundamental Analysis for Value Stock Selection - Newser
Citius Oncology Inc Azioni (CTOR) Dati Finanziari
Non sono disponibili dati finanziari per Citius Oncology Inc (CTOR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):